Neurocrine Biosciences, Inc. · NASDAQ:NBIX
Cooke Julie sold 36,937 Neurocrine Biosciences, Inc. shares (Form 4)
Traded Jun 2, 2026 · Filed Jun 4, 2026
On Jun 2, 2026, Cooke Julie (Chief Human Resources Officer) sold 36,937 Neurocrine Biosciences, Inc. shares at an average US$156.22 for US$5.77M under a trading plan, leaving 22,374 shares. Filed Jun 4, 2026 (Form 4).
- Sold
- 36,937 shares
- Price
- US$156.22 average (US$154.83 to US$158.59)
- Value
- US$5.77M
- Holding after
- 22,374 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Human Resources Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | Option exercise | 24,965 | US$81.49 | 59,311 | Direct |
| Jun 2, 2026 | Common Stock | Sale | 14,214 | US$154.83 | 45,097 | Direct |
| Jun 2, 2026 | Common Stock | Sale | 5,466 | US$155.46 | 39,631 | Direct |
| Jun 2, 2026 | Common Stock | Sale | 4,216 | US$156.77 | 35,415 | Direct |
| Jun 2, 2026 | Common Stock | Sale | 9,521 | US$157.62 | 25,894 | Direct |
| Jun 2, 2026 | Common Stock | Sale | 3,520 | US$158.59 | 22,374 | Direct |
Source
Related
- Neurocrine Biosciences, Inc.
- Cooke Julie
- Neurocrine Biosciences, Inc. shareholders
- Form 4 · Cooke Julie · Sep 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 15, 2026
- Form 4 · Boyer David W. · Sep 15, 2026
- Form 4 · Abernethy Matt · Sep 15, 2026
- Form 4 · Gano Kyle · Sep 15, 2026
- Form 4 · Onyia Jude · Sep 15, 2026